These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3393555)

  • 1. Neoadjuvant chemotherapy in T3-4 N0-X M0 transitional cell carcinoma of the bladder. Problems of clinical and pathological evaluation of response.
    Splinter TA; ten Kate FJ; Schröder FH; Denis L; Newling D; Jones WG; Jacqmin D; Boeken Kruger CG; Stoter G; de Voogt HJ
    Prog Clin Biol Res; 1988; 269():579-90. PubMed ID: 3393555
    [No Abstract]   [Full Text] [Related]  

  • 2. Preoperative chemotherapy in T3-T4 Nx Mo bladder cancer with cisplatinum and methotrexate.
    Denis L; Da Silva FC; Hendrickx L
    Prog Clin Biol Res; 1988; 260():571-7. PubMed ID: 3362906
    [No Abstract]   [Full Text] [Related]  

  • 3. [Neoadjuvant chemotherapy using cisplatin (CDDP) and methotrexate (MTX) in carcinoma of the bladder].
    Rocco F; Scardino E; Strada G; Franchini V; Larcher P; Favini P; Baccalin A; Giuberti A; Criscpino S; Tancini G
    Arch Ital Urol Nefrol Androl; 1990 Jun; 62(2):249-55. PubMed ID: 2142809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neo-adjuvant M-VAC chemotherapy trials in transitional cell carcinoma: perspectives for first line chemotherapy.
    Sternberg CN; Yagoda A; Scher HI; Whitmore WF; Herr HW; Morse MJ; Sogani PC; Bosl G; Watson RC; Hollander PS
    Prog Clin Biol Res; 1988; 260():551-5. PubMed ID: 3283770
    [No Abstract]   [Full Text] [Related]  

  • 5. The cisplatin-methotrexate neo-adjuvant protocol as first-line therapy of bladder cancer. Present experience in Palermo.
    Ingargiola GB; Lamartina M; Cassata G; Corselli G; Serretta V; Caramia G; Rizzo FP; Pavone-Maculuso M
    Prog Clin Biol Res; 1988; 260():579-83. PubMed ID: 3362907
    [No Abstract]   [Full Text] [Related]  

  • 6. Neoadjuvant chemotherapy for bladder cancer: the MSKCC experience.
    Fair WR; Scher H; Herr H; Morse M; Sogani P; Bosi G; Dershaw D; Reuter V; Curley T
    Semin Urol; 1990 Aug; 8(3):190-6. PubMed ID: 2399387
    [No Abstract]   [Full Text] [Related]  

  • 7. Pre-cystectomy chemotherapy with sequentially administered cisplatin, cyclophosphamide and adriamycin in invasive transitional cell carcinoma of the bladder (preliminary report).
    Guazzieri S; Sperandio P; Fandella A; Garbeglio A; Pegoraro V; Chiarion V; Fiorentino M; Pagano F
    Prog Clin Biol Res; 1988; 260():599-602. PubMed ID: 3362909
    [No Abstract]   [Full Text] [Related]  

  • 8. Chemotherapy for advanced urothelial cancer.
    Yagoda A
    Semin Urol; 1983 Feb; 1(1):60-74. PubMed ID: 6382528
    [No Abstract]   [Full Text] [Related]  

  • 9. Adjunctive adjuvant or neoadjuvant chemotherapy for locally advanced bladder cancer: a critical appraisal of the present status.
    Walther PJ
    Semin Urol; 1993 Nov; 11(4):227-34. PubMed ID: 8290828
    [No Abstract]   [Full Text] [Related]  

  • 10. Pre surgery chemotherapy in bladder cancer.
    Francini M; Veronesi A; Dal Bo V; Carbone A; Monfardini S
    Prog Clin Biol Res; 1988; 260():585-9. PubMed ID: 3362908
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical study of neoadjuvant intraarterial chemotherapy (I A-MAC) for advanced bladder cancer].
    Takahashi Y; Deguchi T; Kuriyama M; Nakano M; Ueno K; Shinoda I; Takeda A; Itoh S; Doi T; Takeuchi T
    Gan To Kagaku Ryoho; 1994 Sep; 21(13):2311-4. PubMed ID: 7944467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Systemic chemotherapy in advanced bladder cancer. New aspects].
    Jakse G
    Wien Klin Wochenschr; 1987 Jan; 99(2):54-7. PubMed ID: 3564487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy for metastatic bladder cancer; the EORTC experience.
    Stoter G
    Prog Clin Biol Res; 1988; 260():471-9. PubMed ID: 3283767
    [No Abstract]   [Full Text] [Related]  

  • 14. Impact of methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy in patients with lymph node metastases from transitional cell carcinoma of the lower urinary tract.
    Koch MO; Coussens D
    Semin Urol; 1993 Feb; 11(1):14-9. PubMed ID: 8465122
    [No Abstract]   [Full Text] [Related]  

  • 15. [Is neoadjuvant chemotherapy valid in invasive cancer of the bladder?].
    Matveev BP; Figurin KM
    Urol Nefrol (Mosk); 1998; (6):42-5. PubMed ID: 10051828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant chemotherapy for non-organ confined bladder transitional cell carcinoma.
    Abi-Aad AS
    Acta Urol Belg; 1996 May; 64(2):35-7. PubMed ID: 8701808
    [No Abstract]   [Full Text] [Related]  

  • 17. [Aggressive preoperative chemotherapy in infiltrating bladder carcinoma with a combination of cisplatin, cyclophosphamide and adriamycin. Preliminary report].
    Martínez-Piñeiro JA; de la Peña JJ; Hidalgo L; Cisneros J; Jiménez de León J; Machuca J
    Arch Esp Urol; 1986; 39(1):33-46. PubMed ID: 3707210
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
    George L; Bladou F; Bardou VJ; Gravis G; Tallet A; Alzieu C; Serment G; Salem N
    Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary cisplatin, methotrexate and vinblastine aiming at bladder preservation in invasive bladder cancer: multivariate analysis on prognostic factors.
    Angulo JC; Sanchez-Chapado M; Lopez JI; Flores N
    J Urol; 1996 Jun; 155(6):1897-902. PubMed ID: 8618282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [MEC treatment (methotrexate, etoposide, cisplatin) for urothelial cancer].
    Miura T; Murai T; Shimura H; Kondo I
    Gan To Kagaku Ryoho; 1992 May; 19(5):731-3. PubMed ID: 1580650
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.